Bustamante, Reynald T.

HRN: 28-62-55  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
CEFTRIAXONE 1G (VIAL)
02/26/2026
03/05/2026
IV
1gm
Q12
TC Blunt Abd Trauma Sec To RCI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: